GenesisTissue is a biotechnology company redefining breast reconstruction and cosmetic surgery through personalized 3D bioprinting. Its mission is to replace silicone implants with living, regenerative tissue—creating natural, life-long outcomes for every patient. The company’s Regenerative Breast Tissue platform combines precision bioprinting, material innovation, and personalized design to bring “replace like with like” to life. GenesisTissue products described in this release are investigational and in development. They have not been cleared or approved by the FDA and are not available for commercial sale.